149 related articles for article (PubMed ID: 23188672)
1. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility.
Jiang Y; Qin Z; Hu Z; Guan X; Wang Y; He Y; Xue J; Liu X; Chen J; Dai J; Jin G; Ma H; Wang S; Shen H
Carcinogenesis; 2013 Mar; 34(3):689-93. PubMed ID: 23188672
[TBL] [Abstract][Full Text] [Related]
2. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
[TBL] [Abstract][Full Text] [Related]
3. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
7. A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese.
Lu C; Chen YD; Han S; Wei J; Ge Y; Pan W; Jiang T; Qiu XG; Yang M
J Neurooncol; 2014 Oct; 120(1):11-7. PubMed ID: 25012956
[TBL] [Abstract][Full Text] [Related]
8. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
9. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
Tchatchou S; Jung A; Hemminki K; Sutter C; Wappenschmidt B; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Ditsch N; Meindl A; Schmutzler RK; Bartram CR; Burwinkel B
Carcinogenesis; 2009 Jan; 30(1):59-64. PubMed ID: 19028706
[TBL] [Abstract][Full Text] [Related]
10. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
[TBL] [Abstract][Full Text] [Related]
12. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk.
Naccarati A; Pardini B; Stefano L; Landi D; Slyskova J; Novotny J; Levy M; Polakova V; Lipska L; Vodicka P
Carcinogenesis; 2012 Jul; 33(7):1346-51. PubMed ID: 22581836
[TBL] [Abstract][Full Text] [Related]
14. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
15. Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.
Pardini B; Rosa F; Barone E; Di Gaetano C; Slyskova J; Novotny J; Levy M; Garritano S; Vodickova L; Buchler T; Gemignani F; Landi S; Vodicka P; Naccarati A
Clin Cancer Res; 2013 Nov; 19(21):6044-56. PubMed ID: 24036853
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
[TBL] [Abstract][Full Text] [Related]
17. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R; Schlehe B; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Volkmann J; Varon R; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2010 Jun; 121(3):693-702. PubMed ID: 19921425
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
Brendle A; Lei H; Brandt A; Johansson R; Enquist K; Henriksson R; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jul; 29(7):1394-9. PubMed ID: 18550570
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
20. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
